Skip to content
Research Article Open access CC BY 4.0

A Wonder Drug in the Arsenal against COVID - 19: Medication Evidence from Ivermectin

B. Suresh Kumar, Madhan Jeyaraman, Rashmi Jain, Talagavadi Channaiah Anudeep

Journal of Advances in Medicine and Medical Research · pp. 30–37 · Published 6 Jul 2020

10.9734/jammr/2020/v32i1030512

Abstract

Ivermectin, an FDA approved broad-spectrum anti-parasitic agent has been recently reported to show an inhibitory activity against SARS-CoV-2 in an in-vitro study. This antiviral response has rendered it as a potential drug to be repurposed for COVID-19. Previously, ivermectin had showed inhibitory activity against RNA viruses in-vitro and DNA viruses in-vitro and in-vivo respectively. Much of its characterization has been related to SARS-CoV wherein viral proteins interacting with IMPα/β1 (Importins) were proposed to enhance the viral infectivity. These documentations serve as a ray of hope for considering ivermectin in treating COVID-19 due to its suggested nuclear transport inhibitory mechanism. Importantly, these recent findings warrant detailed investigations for understanding its benefit in terms of efficacy and safety in COVID-19 patients. This review article throws light on the current consensus in this regard.

COVID-19 SARS-CoV-2 SARS-CoV ivermectin

Cited by 6

Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?

David A. Jans, Kylie M. Wagstaff · Cells · 2020

Predictors of COVID-19 Vaccine Acceptance Among Nigerian Medical Doctors

CA Nri-Ezedi, C Okechukwu, OC Ofiaeli · Annals of Health Research · 2022

The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?

David A. Jans, Kylie M. Wagstaff · Biochemical and Biophysical Research Communications · 2021

The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review

Asiya Kamber Zaidi, Puya Dehgani-Mobaraki · The Journal of Antibiotics · 2021

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

6

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.